Effect of Ginger on reducing nausea and vomiting and on quality of life in patients undergoing Chemotherapy
Not Applicable
Recruiting
- Conditions
- Cancer. Nauseas and vomiting.C23.888.821.712C23.888.821.937
- Registration Number
- RBR-33jpyy
- Lead Sponsor
- Hospital das Clínicas Universidade Federal de Goiás - GO
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Aged between 20 and 80 years;
Individuals apt of swallowing capsules; Individuals with a confirmed diagnosis of cancer, being treated with chemotherapy ; Individuals who have undergone at least one CT cycle with the same chemotherapeutic agent and who have experienced nausea or vomiting as a result of such treatment; Individuals with platelet counts> 100 000/microliters before the initialcycle.
Exclusion Criteria
Individuals with ginger allergy or who have made use of it in the last week; Patients on heparin or other anticoagulant medication or who have some bleeding disorder; Patients submitted to chemoterapy associated radiotherapy during the study period.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction of nausea and vomiting as assessed by the Multinational Association on Supportive Care in Cancer (MASCC). It is intended to verify a reduction of at least 2 units in the intensity and frequency of nausea and vomiting.
- Secondary Outcome Measures
Name Time Method Quality of life as measured by the EORTC QLQ-C30 assessment method.<br>It is expected to improve, at any intensity, on the psychometric properties of EORTEC QLQ-C30.